Am J Transplant, Volume 21, Suppl 3 Archives - Page 3 of 139 - ATC Abstracts

2021 American Transplant Congress
Impact of Belatacept and Tacrolimus on Cmv Viral Load Control and Relapse in Moderate and High-risk Cmv Serostatus Kidney Transplant Recipients
W. Magua¹, A. C. Johnson¹, G. M. Karadkhele¹, I. R. Badell¹, P. Vasanth¹, M. G. Lyon III², A. K. Mehta², K. A. Easley³, J. Rickert⁴, C. P. Larsen¹
¹Department of Surgery, Emory University, Atlanta, GA, ²Department of Medicine, Emory University, Atlanta, GA, ³Biostatistics and Bioinformatics, Emory University, Atlanta, GA, ⁴RStudio and R Consortium, San Jose, CA
*Purpose: We aim to evaluate the impact of belatacept and tacrolimus on CMV viral load control, remission and relapse in CMV high-risk (serostatus, D+/R-) and…
2021 American Transplant Congress
Significance of Detectable but Unquantifiable Viremias Post Renal Transplantation
M. Chaung, S. Puri, S. Bunin, Z. Mondal, O. Eletta, R. Pelletier, A. Bongu
Robert Wood Johnson University Hospital, New Brunswick, NJ
*Purpose: It is unknown whether the degree of the initial viremia following kidney (KT) or combined kidney-pancreas transplantation (SPKT) correlates with future allograft rejection or…
2021 American Transplant Congress
Outcomes of Deceased Donor Transplants with Donor Specific Antibodies Before and After the New Kidney Allocation System
R. Crew, P. Khairallah, S. S. Patel
Columbia University, New York, NY
*Purpose: KAS forced centers to list unacceptable HLA antigens. Some centers excluded antigens at any level of anti-HLA Ab. Our center only excluded antibodies posing…
2021 American Transplant Congress
Outcomes in Highly Sensitized Kidney Transplant Recipients Receiving DCD Organs
A. Diamond¹, L. Rodrigues², A. Di Carlo³, S. Karhadkar³
¹Pharmacy, Temple University Hospital, Philadelphia, PA, ²Temple University, Philadelphia, PA, ³Surgery, Temple University Hospital, Philadelphia, PA
*Purpose: Highly sensitized (HS) patients experience longer wait times for kidney transplantation despite prioritization by the Kidney Allocation System. Kidney transplants performed from donors defined…
2021 American Transplant Congress
Efficacy of Hope: Analysis of Quality HIV+ Deceased Donor Organ Availability
G. E. Owens¹, B. Shelton¹, P. MacLennan¹, D. Sawinski², J. E. Locke¹
¹Transplant, University of Alabama at Birmingham, Birmingham, AL, ²Transplant, University of Pennsylvania, Philadeplphia, PA
*Purpose: The purpose of this study is to understand the number of organs actually available for HIV+ to HIV+ transplant utilizing data on a national…
2021 American Transplant Congress
The Impact of Health Literacy on Kidney Transplant Listing
G. Chen¹, J. Siahaan², L. Leon Novelo², I. Rizvi³, A. M. De Golovine⁴, A. R. Edwards⁴, A. Pai⁴, W. A. Dar³
¹Abdominal Transplant, Memorial Hermann Hospital, Houston, TX, ²Department of Biostatistics and Data Science, School of Public Health The University of Texas Health Science Center at Houston, Houston, TX, ³Department of Surgery, McGovern Medical School The University of Texas Health Science Center at Houston, Houston, TX, ⁴Department of Internal Medicine, Renal Diseases and Hypertension, McGovern Medical School The University of Texas Health Science Center at Houston, Houston, TX
*Purpose: Limited health literacy has long been associated with poor health outcomes in the general population, but there have been few studies investigating the association…
2021 American Transplant Congress
How Should Acute T-Cell Mediated Rejection of Kidney Transplants be Treated?
F. Aziz¹, S. Parajuli², N. Garg², M. Mohamed², A. Djamali², D. Mandelbrot²
¹University of Wisconsin, Madison, WI, ²University of Wisconsin, Verona, WI
*Purpose: Many guidelines suggest treating acute T-cell mediated rejection (TCMR) of kidney allografts that is Banff grade I with steroids alone and Banff grade II…
2021 American Transplant Congress
Effect of Insulin versus Oral Agents on Early Glycemic Control Following Kidney Transplant
A. Petrosan, A. Santeusanio, R. Khaim, V. Delaney
Mount Sinai Hospital, New York, NY
*Purpose: Insulin therapy is commonly prescribed to treat hyperglycemia early post-kidney transplant (KTx) due to its widespread availability and ease of titration. Alternatively, there is…
2021 American Transplant Congress
A Question with Multiple Answers: Do Renal Transplant Recipients Require Steroid Maintenance Following Thymoglobulin Induction?
A. Aala, H. Patel, F. Cardarelli
Beth Israel Deaconess Medical Center, Boston, MA
*Purpose: Anti-thymocyte globulin (ATG) has been used with good results in renal transplantation as induction therapy, followed by triple immunosuppression with calcineurin inhibitors, antimetabolites, and…
2021 American Transplant Congress
A Comparison of Belatacept Conversion Regimens from Calcineurin Inhibitor-Based Immunosuppression
E. Huang, A. Vo, A. Peng, R. Najjar, S. Sethi, S. Jordan
Cedars-Sinai Medical Center, Los Angeles, CA
*Purpose: Outcomes with varying belatacept conversion protocols from calcineurin inhibitor (CNI)-based immunosuppression have been published but no standard protocol has been established. Beginning in 2012,…